Tamar Rubinek

2.8k total citations
50 papers, 1.6k citations indexed

About

Tamar Rubinek is a scholar working on Genetics, Molecular Biology and Nephrology. According to data from OpenAlex, Tamar Rubinek has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 23 papers in Molecular Biology and 21 papers in Nephrology. Recurrent topics in Tamar Rubinek's work include Parathyroid Disorders and Treatments (21 papers), Genetic Syndromes and Imprinting (20 papers) and Metabolism, Diabetes, and Cancer (6 papers). Tamar Rubinek is often cited by papers focused on Parathyroid Disorders and Treatments (21 papers), Genetic Syndromes and Imprinting (20 papers) and Metabolism, Diabetes, and Cancer (6 papers). Tamar Rubinek collaborates with scholars based in Israel, United States and Czechia. Tamar Rubinek's co-authors include Ido Wolf, Bella Kaufman, Hagai Ligumsky, Keren Merenbakh-Lamin, Ilan Shimon, Moshe Hadani, Beth Y. Karlan, Adva Yeheskel, Hannah Kanety and Makoto Kuro‐o and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Tamar Rubinek

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamar Rubinek Israel 23 671 638 534 306 303 50 1.6k
Jonathan M. Shillingford United States 20 1.4k 2.1× 1.2k 1.9× 185 0.3× 503 1.6× 103 0.3× 28 2.2k
Tomohiko Yamamura Japan 22 786 1.2× 310 0.5× 319 0.6× 457 1.5× 51 0.2× 128 1.9k
Stephen J. Klaus United States 16 774 1.2× 253 0.4× 160 0.3× 190 0.6× 59 0.2× 21 2.0k
Sandra Mifsud Australia 19 628 0.9× 135 0.2× 147 0.3× 478 1.6× 64 0.2× 39 1.7k
Akira Inomata Japan 10 1.1k 1.6× 143 0.2× 79 0.1× 858 2.8× 164 0.5× 26 1.7k
Jianyin Long United States 21 2.4k 3.6× 182 0.3× 366 0.7× 513 1.7× 59 0.2× 28 3.1k
Kunimasa Yan Japan 23 561 0.8× 247 0.4× 727 1.4× 83 0.3× 92 0.3× 52 1.4k
Francesco Pacifico Italy 25 1.1k 1.6× 99 0.2× 91 0.2× 352 1.2× 264 0.9× 46 1.8k
Helge Ræder Norway 28 1.1k 1.6× 1.3k 2.1× 254 0.5× 232 0.8× 828 2.7× 65 2.6k
Hidehiko Fujinaka Japan 21 570 0.8× 123 0.2× 364 0.7× 90 0.3× 56 0.2× 63 1.2k

Countries citing papers authored by Tamar Rubinek

Since Specialization
Citations

This map shows the geographic impact of Tamar Rubinek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamar Rubinek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamar Rubinek more than expected).

Fields of papers citing papers by Tamar Rubinek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamar Rubinek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamar Rubinek. The network helps show where Tamar Rubinek may publish in the future.

Co-authorship network of co-authors of Tamar Rubinek

This figure shows the co-authorship network connecting the top 25 collaborators of Tamar Rubinek. A scholar is included among the top collaborators of Tamar Rubinek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamar Rubinek. Tamar Rubinek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ligumsky, Hagai, Sharon Amir, Tali Scherf, et al.. (2024). Glucagon-like peptide-1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells. Medical Oncology. 41(6). 138–138. 3 indexed citations
2.
Merenbakh-Lamin, Keren, Hagai Ligumsky, Moshe Giladi, et al.. (2023). Revealing the tumor suppressive sequence within KL1 domain of the hormone Klotho. Oncogene. 43(5). 354–362. 3 indexed citations
3.
Gadoth, Avi, Yifat Alcalay, Idit F. Schwartz, et al.. (2023). Electrolyte Imbalance in Anti-LGI1 Encephalitis. Neurology Neuroimmunology & Neuroinflammation. 10(6). 6 indexed citations
4.
Ligumsky, Hagai, et al.. (2022). The role of α-klotho in human cancer: molecular and clinical aspects. Oncogene. 41(40). 4487–4497. 31 indexed citations
5.
6.
Merenbakh-Lamin, Keren, Anat Klein, Metsada Pasmanik‐Chor, et al.. (2019). Ligand-binding Domain–activating Mutations of ESR1 Rewire Cellular Metabolism of Breast Cancer Cells. Clinical Cancer Research. 25(9). 2900–2914. 29 indexed citations
7.
Rubinek, Tamar & Ido Wolf. (2016). The Role of Alpha-Klotho as a Universal Tumor Suppressor. Vitamins and hormones. 101. 197–214. 36 indexed citations
8.
Rubinek, Tamar & Dalit Modan‐Moses. (2016). Klotho and the Growth Hormone/Insulin-Like Growth Factor 1 Axis. Vitamins and hormones. 101. 85–118. 23 indexed citations
9.
Rubinek, Tamar, Ayelet Shabtay‐Orbach, Yael Levy‐Shraga, et al.. (2016). Klotho response to treatment with growth hormone and the role of IGF-I as a mediator. Metabolism. 65(11). 1597–1604. 23 indexed citations
10.
Ligumsky, Hagai, Tamar Rubinek, Keren Merenbakh-Lamin, et al.. (2015). Tumor Suppressor Activity of Klotho in Breast Cancer Is Revealed by Structure–Function Analysis. Molecular Cancer Research. 13(10). 1398–1407. 39 indexed citations
11.
Wolf, Ido, Dan J. Stein, Rina Hemi, et al.. (2015). Alteration in serum klotho levels in anorexia nervosa patients. Clinical Nutrition. 35(4). 958–962. 13 indexed citations
12.
Wolf, Ido, Yael Levy‐Shraga, Kineret Mazor‐Aronovitch, et al.. (2014). Association between Decreased Klotho Blood Levels and Organic Growth Hormone Deficiency in Children with Growth Impairment. PLoS ONE. 9(9). e107174–e107174. 20 indexed citations
13.
Hasson, Shira Peleg, Tamar Rubinek, L Ryvo, & Ido Wolf. (2013). Endocrine Resistance in Breast Cancer: Focus on the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway. Breast Care. 8(4). 248–255. 39 indexed citations
14.
Rubinek, Tamar, Shikha Bose, Ayelet Avraham, et al.. (2011). Epigenetic silencing of the tumor suppressor klotho in human breast cancer. Breast Cancer Research and Treatment. 133(2). 649–657. 88 indexed citations
15.
Wolf, Ingo, Yael Laitman, Tamar Rubinek, et al.. (2009). Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin. Oncogene. 29(1). 26–33. 40 indexed citations
16.
Chesnokova, Vera, Svetlana Zonis, Tamar Rubinek, et al.. (2007). Senescence Mediates Pituitary Hypoplasia and Restrains Pituitary Tumor Growth. Cancer Research. 67(21). 10564–10572. 81 indexed citations
17.
Rubinek, Tamar, Vera Chesnokova, Ido Wolf, et al.. (2007). Discordant proliferation and differentiation in pituitary tumor-transforming gene-null bone marrow stem cells. American Journal of Physiology-Cell Physiology. 293(3). C1082–C1092. 13 indexed citations
18.
Shimon, Ilan, et al.. (2004). PTR-3173 (Somatoprim™), a novel somatostatin analog with affinity for somatostatin receptors 2, 4 and 5 is a potent inhibitor of human GH secretion. Journal of Endocrinological Investigation. 27(8). 721–727. 30 indexed citations
19.
Rubinek, Tamar, Mary Bakhanashvili, Ran Taube, Orna Avidan, & Amnon Hizi. (1997). The Fidelity of 3′ Misinsertion and Mispair Extension During DNA Synthesis Exhibited by two Drug‐Resistant Mutants of the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 with Leu74→Val and Glu89→Gly. European Journal of Biochemistry. 247(1). 238–247. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan M. Shillingford Breakdown of academic impact, for papers by Tomohiko Yamamura Breakdown of academic impact, for papers by Stephen J. Klaus Breakdown of academic impact, for papers by Sandra Mifsud Breakdown of academic impact, for papers by Akira Inomata Breakdown of academic impact, for papers by Jianyin Long Breakdown of academic impact, for papers by Kunimasa Yan Breakdown of academic impact, for papers by Francesco Pacifico Breakdown of academic impact, for papers by Helge Ræder Breakdown of academic impact, for papers by Hidehiko Fujinaka
Rankless by CCL
2026